When: Confirmed close above $1,300 on volume >4M shares

Then: Add final 1/3 of target position

HOLD with 20-25% trim into $1,260-$1,300 zone

• PEG ratio of 0.45 only valid at peak 59% consensus growth; drops to 0.68 at 40%, 0.90 at 30%, and 1.35 at 20% growth - making current valuation less attractive at realistic growth rates
• Stock is 22.4% above 200 SMA which has risen 16% in four months - steep slope invites violent mean reversion
• $3.48 billion in special charges represents ~15% of quarterly net income; total debt up 37.6% YoY to $46 billion net debt with 162% debt-to-equity ratio
• Four to five oral GLP-1 entrants expected by 2028 poses commoditization risk to pricing moat; IRA pricing pressure should be discounted starting 2026, not 2027-2028
• Acquisition integration risk is real and rising leverage in higher-for-longer rate environment creates genuine earnings headwind
• Bull case requires sustained execution across multiple dimensions: 47% revenue growth, $8.75B acquisition integration, IRA margin defense, competitive market share defense, and capacity expansion
• Beta of 0.5 with ATR of 42 points (3.3% daily volatility) means downside risk is real regardless of long-term direction
• Trimming into strength preserves dry powder for 5-10% pullback opportunities to add positions at better risk-adjusted entry points

→ vs aggressive: PEG ratio of 0.45 is based on optimistic 59% consensus growth estimates; realistic growth scenarios (30-40%) yield PEG of 0.68-0.90, eliminating the discount valuation argument

→ vs aggressive: Technical analysis framing is survivorship bias - past breakout legs that reversed are not counted; 22.4% extension above 200 SMA with steep slope invites mean reversion

→ vs aggressive: IRA and oral GLP-1 risks should be discounted starting 2026, not ignored as distant calendar items; 4-5 competitors by 2028 represents commoditization of pricing moat

→ vs aggressive: Debt-financed acquisition is not risk-neutral; $46B net debt at 162% debt-to-equity with higher-for-longer rates creates real earnings headwind

→ vs aggressive: Trimming is 'performance anxiety' framing is a rhetorical flourish, not analysis; 20-25% trim into $1,260-$1,300 is methodical profit-taking, not panic selling

→ vs aggressive: Bear case framing as 'strawman requiring multiple things to go wrong' ignores that bull case also requires sustained multi-dimensional execution across growth, integration, pricing defense, and competition

HOLD with 10-15% trim into $1,260-$1,300 zone; tiered entry plan preserved; trailing stop anchored at 200 SMA

• PEG ratio is 0.90 at 30% sustained EPS growth and 1.08 at 25% growth—neither screaming cheap nor obviously expensive; valuation is reasonable if growth holds, vulnerable if it slows
• Technical setup is extended: price 22.4% above 200 SMA, 9.1% above 50 SMA, 5.6% above 10 EMA, just closed above upper Bollinger Band, RSI at 65—collectively indicating easy money has been made
• Probability-weighted 12-month price distribution: 25% bull case ($1,400-$1,500), 50% base case ($1,150-$1,350), 20% bear case ($900-$1,100), 5% tail case (sub-$900), yielding expected price of $1,260-$1,290 (roughly flat from current levels)
• Recommend 10-15% trim (more conservative than 20-25% suggested) to harvest volatility premium given 3.3% daily ATR with ~flat expected 12-month return
• Asymmetric trim math: trimming 15% at $1,280 that runs to $1,400 leaves ~$2.70 per original share on the table, but creates dry powder to buy back more shares if LLY pulls to $1,150
• IRA pricing risk should be assessed as evolving probability distribution (not binary 2027-2028 event), with multiple compression possible before the actual date if probability shifts
• M&A de-risks GLP-1 concentration but D/E of 162% and 37.6% YoY debt increase constrain future capital allocation—both acquisition benefits and costs are priced in
• Stop framework: partial de-risk on close below 50 SMA at $1,173; full exit on close below 200 SMA at $1,046
• Tiered entry plan: 1/3 at $1,150 (near 50 SMA), 1/3 at $1,050 (near 200 SMA), 1/3 on confirmed breakout above $1,300 with volume—this respects both trend and entry discipline
• Aggressive analyst correct on fundamentals but wrong to dismiss entry point and trim necessity; Conservative analyst correct on risk discipline but wrong on trim magnitude and characterizing business as anything other than elite

→ vs aggressive: Wrong that any trim is performance anxiety; wrong that entry point doesn't matter; wrong that technical setup is unambiguously bullish when sitting above upper Bollinger Band with price 5.6% above 10 EMA and RSI at 65

→ vs aggressive: Treats IRA pricing as future event with no present consequences when markets continuously reprice probability distributions as information accumulates

→ vs conservative: Wrong that trim needs to be 20-25%; wrong to imply underlying business is anything other than elite with 47% revenue growth, 54% operating margins, $11B FCF, and confirmed $1T milestone

→ vs conservative: Wrong to suggest bear case requires multiple things to go wrong; real question is distribution of outcomes 12 months from now, where bear case has 20% probability with single catalysts like IRA acceleration, oral GLP-1 entry, or pipeline disappointment

→ vs conservative: Wrong to fight the tape rather than acknowledge trend and respect entry simultaneously